All In Biotech

Drug Trial Radar · NCT00804141

Study Evaluating Long-Term Safety of MOA-728 in Participants With Opioid-Induced Constipation

An Open-Label Study to Evaluate the Long-Term Safety of Subcutaneous MOA-728 for Treatment of Opioid-Induced Constipation in Subjects With Nonmalignant Pain

Last checked: Nov 19, 2026Latest source record: Oct 18, 2019 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

1,040

Actual

Start

Dec 3, 2008

Primary completion

Sep 20, 2010

Study completion Sep 20, 2010

Sponsor

Lead sponsor
Bausch Health Americas, Inc.Industry
Sponsor type
Industry
Collaborators
Pfizer
First posted
Dec 8, 2008

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study is designed to evaluate the long-term safety and tolerability of the subcutaneous (SC) injection form of N-methylnaltrexone bromide (MOA-728) for the treatment of opioid-induced constipation in participants with nonmalignant pain. The study consists of a 2-week screening period, a 48-week open-label treatment period and a 2 week follow-up period. Participants will need to agree to self-administer SC injections, complete daily diaries, and check-in via a daily telephone call during the study.

Conditions

  • Constipation

Interventions

  • N-methylnaltrexone bromide (MOA-728)Drug

    MOA-728 will be administered as per the dose and schedule specified in the arm.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Participants With Treatment-Emergent Adverse Events (TEAEs)Time frame: Baseline up to Week 50

Locations

120 sites in 6 countries. Site status is shown where the registry gives one.

  • Pfizer Investigational Site

    Birmingham, Alabama

  • Pfizer Investigational Site

    Chandler, Arizona

  • Pfizer Investigational Site

    Mesa, Arizona

  • Pfizer Investigational Site

    Mesa, Arizona

  • Pfizer Investigational Site

    Phoenix, Arizona

  • Pfizer Investigational Site

    Phoenix, Arizona

  • Pfizer Investigational Site

    Tempe, Arizona

  • Pfizer Investigational Site

    Tucson, Arizona

  • Pfizer Investigational Site

    Tucson, Arizona

  • Pfizer Investigational Site

    Hot Springs, Arkansas

  • Pfizer Investigational Site

    Garden Grove, California

  • Pfizer Investigational Site

    Laguna Hills, California

  • Pfizer Investigational Site

    Los Gatos, California

  • Pfizer Investigational Site

    Newport Beach, California

  • Pfizer Investigational Site

    Newport Beach, California

  • Pfizer Investigational Site

    Colorado Springs, Colorado

  • Pfizer Investigational Site

    Boca Raton, Florida

  • Pfizer Investigational Site

    Brandon, Florida

  • Pfizer Investigational Site

    Chiefland, Florida

  • Pfizer Investigational Site

    Clearwater, Florida

  • Pfizer Investigational Site

    Daytona Beach, Florida

  • Pfizer Investigational Site

    Fort Myers, Florida

  • Pfizer Investigational Site

    Gainesville, Florida

  • Pfizer Investigational Site

    Jacksonville, Florida

  • Pfizer Investigational Site

    Jacksonville, Florida

  • Pfizer Investigational Site

    Jupiter, Florida

  • Pfizer Investigational Site

    Miami, Florida

  • Pfizer Investigational Site

    Miami, Florida

  • Pfizer Investigational Site

    Ocala, Florida

  • Pfizer Investigational Site

    Ocala, Florida

  • Pfizer Investigational Site

    Ocala, Florida

  • Pfizer Investigational Site

    Orlando, Florida

  • Pfizer Investigational Site

    Ormond Beach, Florida

  • Pfizer Investigational Site

    Port Orange, Florida

  • Pfizer Investigational Site

    Sarasota, Florida

  • Pfizer Investigational Site

    Sarasota, Florida

  • Pfizer Investigational Site

    Tampa, Florida

  • Pfizer Investigational Site

    Tampa, Florida

  • Pfizer Investigational Site

    Vero Beach, Florida

  • Pfizer Investigational Site

    Winter Park, Florida

Showing 40 of 120 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.